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a resting ECG, in 7304 Framingham Heart Study subjects (3965 women; mean age 46 
years) who attended a routine examination and had no prior AF. Sex-specific Cox propor- 
tional hazards regression models were used to examine Me association of PR interval 
with risk of AF after adjusting for age, BMI, smoking, hypertension, diabetes, valve dis- 
ease, MI or CHF [time-dependent covariate]), presence of atrial premature beats and lef! 
ventricular hyperfrophy. 
Results: On follow up (mean 21 years), 624 subjects (290 women) developed AF. In 
multivariable models adjusting for established risk factors, a nonlinear relation was noted 
between PR intewal and risk of AF. Comparing subjects with short (co.12 set) and pro- 
longed PR intervals (>0.20 set) with those with a normal PR (0.12-0.20). a prolonged PR 
interval was associated with increased risk of AF in both sexes (Table). 
Conclusions: Contrary to previous reports, a prolonged PR interval is not a benign con- 
dition. It is associated with increased risk of AF, perhaps because it identifies subjects 
with nonuniform or delayed atrial conduction. 
PR Interval and Risk 01 lncldent AF 
category Men Women 
No. AF/ No. at Risk HR (95% Cl)’ No. AF/ No. at Risk HR (95% Cl) 
Normal PR 
Short PR 
Long PR 
313/3176 1 .O (Referent) 
6/60 1.9 (0.6-4.3) 
15/61 1.7 (1 .o-2.9) 
27613770 1 .O (Referent) 
6/l 76 1.2 (052.6) 
6/29 3.6 (1.7-7.6) 
885 
ORAL CONTRIBUTIONS 
Atrial Fibrillation Ablation: Clinical 
Outcomes 
Wednesday, March 20, 2002, 6:30 a.m.-IO:00 a.m. 
Georgia World Congress Center, Ballroom II 
8:30 a.m. 
885-l Pulmonary Vein Isolation for Treatment of Atrial 
Fibrillation: Impact of Age on Success and 
Complications 
vDresina. Nassir F. Marrouche, David 0. Martin, Christopher Cole, Ahmad Abdul- 
Karim, Robert Bchweikert, Eduardo Saad, Ktzystof Balaban, Patrick Tchou, Walid Saliba, 
Andrea Natale, Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: Isolation of the pulmonary veins (PV) guided by the circular mapping is 
used for treatment of atrial fibrillation (AF). We compare success rates and long term fol- 
low-up in relation to patients age. Methods and Results: One hundred and sixty-six 
patients (135 men; mean age 53+/-H years) presented for focal mapping and ablation of 
paroxysmal (93 patients) persistent (25 patients) and permanent (46 patients) symptom- 
atic AF. All patients failed 3 +/- 0.9 antiarrhythmic drugs (AAD). Success rate and long- 
term follow-up ware assessed in three different age groups. 570 PVs were mapped and 
isolated using the circular mapping technique. The relative risk of recurrence was 2.5 fold 
higher in patients >= 50 years. 
Conclusion: Isolation of the PVs is an effective cure for atrial fibrillation. From our prelim- 
inary data younger patients (age <50 years) seems to benefit the most from PVs isolation 
for the treatment of AF. Moreover, in our series the younger patients experienced no 
major complications. Pulmonary veins isolation could be considered as first line therapy 
in this group of patients. 
Number of patients 
Age-z50 
Group 1 
57 (46/11) 
Age 50-60 
Group 2 
57(47/10) 
Age>60 
Group 3 
52(42/10) 
(M/F) 
Mean age (years) 
Duration (years) 
Left atrial size (cm) 
Follow-up 
Recurrence 
Controlled on AAD 
Tamponade 
Stroke 
41+/-a 
5+/-3 
4+/-0.3 
5.6+/-3.4 
7% (2/57) 
3.5% (2/57) 
0 
0 
55+/-2 
5+/-4 
4.2+/-0.4 
6+/-3.5 
23%(13/57) 
5% (3/57) 
0 
0 
65+/-4 
6+/-3 
4.3+/-0.5 
5.6+/-3.1 
17%(9/52) 
6%(4/57) 
4%(2) 
4% (2) 
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885-2 Clinical Slgnlflcance of Early Recurrence of Atrial 
Fibrillation After Pulmonary lsolatlon in Patients With 
Paroxysmal Atrlal Flbrlllatlon 
H&a&r&, Hiroshi Tada, Mehmet Ozaydin, Amen Chugh, Sohail Hassan, Christoph 
Scharf, Radmira Greenstein, Frank Pelosi, Jr., Bradley P. Knight, S. Adam Strickberger, 
Fred Morady, Univmity of Michigan, Ann Arbor, Michigan. 
Background: Radiofrequency (RF) catheter ablation of the pulmonary vein (PV) ostla 
using a segmental approach Is performed lo electrically disconnect the arrhythmogenic 
foci within the PV’s from the left atrium. Early recurrence of atriaf fibrillation (ERAF) within 
24 hrs after the ablation is occasionally encountered. The clinical significance of ERAF 
has not been evaluated. 
Objective: To determine the prevalence and clinical significance of ERAF after isolation 
of PVs in patients with paroxysmal or persistent atrial fibrillation (AF). 
Methods: PV isolation was performed in 51 men and 11 women (mean age t SD = 52 i 
11 years) who had paroxysmal or persistent AF for 6.2 f 5.6 years. One patient had 
ischemic hearl disease and 3 had noniachemic cardiomyopathy. AF was paroxysmal in 
54 and persistent in 6 patients. All PVs with PV potentials were targeted using activation 
mapping guided with a decapolar Lasso catheter positioned within 5mm of the ostium. 
Complete electrical isolation was determined by elimination of all high-frequency PV 
potentials. ERAF was defined as any episode of atrial fibrillation that occurred within 24 
hours after the ablation procedure. 
Results: In 49 patients. the left superior and inferior and right superior PVs (LSPV, LIPV, 
and RSPV) and in 13 patients, all 4 PVs were targeted. 01 the 196 Pv’s, 163 (95%) were 
completely isolated. In 46 of 62 patients (77%). all targeted PVs were completely iso- 
lated. ERAF occurred in 7 of 62 patients (11%). Among the 7 patients with ERAF, there 
was no significant difference in the Incidence of ERAF between patients who had com- 
plete (n=4) and incomplete (n=3) isolation of all targeted PVs (p=NS). After 55i42 days 
of follow-up, 3 of the 7 patients who had ERAF were free of AF, 1 had significant improve- 
ment in the frequency of symptoms and 3 had no improvement. The incidence of recur- 
rence of AF was similar in patients with ERAF who had complete (2 of 4) and incomplete 
(2 of 3) isolation. 
Conclusions: ERAF within 24 hours may not be predictive of the clinical outcome during 
the first several weeks of follow-up. This implies that ERAF may be caused by a transient 
phenomenon such as an acute inflammatory response. 
9:00 a.m. 
885-3 Pulmonary Veins lsolatlon for Treatment of Atrial 
Fibrillation in Patients With Impaired Left Ventricular 
Function 
Mro Perez-w, Nassir F. Marrouche, Walid Saliba, Christopher Cole, Ahmad 
Abdul-Karim, Robert Schweikett, David 0. Martin, Eduardo Saad. Thomas Dresing, 
Andrea Natale, Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: Pulmonary veins (PVs) isolation for the treatment of atrial fibrillation (AF) 
has been well defined. The efficacy and safety of this approach in patients with impaired 
LV function (LVF) is lacking. In this study we describe the long-term success rates and 
follow-up of PVs isolation using the circular mapping technique in patients with impaired 
LVF. Methods and Results: Out of 182 patients (141 men; mean age 53+/-11 years) 
underwent focal mapping and ablation of AF 17 (9%) presented with impaired LVF (mean 
ejection fraction 38+/-7%, range 25-45%). Mean left atrial size and AF duration were 5+/- 
0.4 cm and 7+/-5 years, respectively. Ten patients had ischemic cardiomyopathy (CM), 3 
idiopathic CM, 3 valvular heart disease, and 1 hypertensive heart disease. All patients 
failed 4 +/- 0.9 antiarrhythmic drugs (AAD). 58 PVs were mapped and successfully 
ablated using circular mapping. After a mean follow-up of 5+/-2 months, 3 patients (17%) 
experienced recurrence of AF. Two are controlled on drugs and one underwent success- 
ful re-ablation. No PV stenosis (SO% narrowing) was seen in these patients. 
Conclusion: Isolation of the PV for the treatment of atrial fibrillation appeared effective 
and safe in patients with impaired LV function. In this preliminary experience, the 
response lo PV isolation of patients with LV dysfunction was similar to the rest of the pop 
ulation undergoing the procedure. 
9:15 a.m. 
885-4 Clinical Significance of Residual Pulmonary Vein 
Potentials After Pulmonary Vein Isolatlon in Patients 
With Paroxysmal Atria1 Fibrillation 
H&t&c& Hiroshi Tada, Mehmet Ozaydin, Sohail Hassan, Christoph Scharf, Aman 
Chugh, Radmira Greenstein, Frank Pelosi, Jr., Bradley P. Knight, S. Adam Strickberger, 
Fred Morady, University of Michigan, Ann Arbor, Minnesota. 
Background: After electrical isolation of pulmonary veins (PVs), low-amplitude, low-fre- 
quency PV potentials may persist despite vigorous attempts at ablation. The purpose of 
this study is to determine tha prevalence end clinical significance of these potentials. 
Methods: In 51 men and 11 women (mean age f SD = 52 f 11 years) with atrial fibrilla- 
tion (duration = 6.2 f 5.6 years; 14 f 12 episodes per month), PV isolation was guided by 
identification of PV potentials recorded with a circular mapping catheter. AIrial fibrillation 
was paroxysmal in 54 and persistent in 6 patients. All PVs with fascicular PV potentials 
were targeted. Radiofrequency (RF) energy was delivered at the earliest activation site 
within 5mm of the ostium at a maximum temperature of 52’C and a power of 35W for 45 
sets. Complete isolation was defined as the elimination of high frequency PV potentials 
and / or dissociation of the electrical activity within a PV from the lefi atrium. Residual 
potentials ware defined as low-amplitude (c0.5mV) and low-frequency potentials that fol- 
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lowed the left atrial electrogram recorded within a PV. 
Results: Electrical isolation was achieved in 56 of 62 left superior PVs (LSPV, 90%). 58 
of 62 right superior PVs (RSPV, 95%) 54 of 60 left inferior PVs (LIPV, 90%) and 14 of 14 
right inferior PVs (RIPV, 100%). After isolation, there were residual low-amplitude, low- 
frequency potentials in 32% of the LSPVs, 16% of the RSPVs. 16% of the LIPVs, and in 
none of the RiPVs. Among the 46 of 62 patients who had complete isolation of all tar- 
geted PVs, there was a residual potential in at least 1 PV in 22 patients (46%). After 55 * 
42 days of follow-up. there was a recurrence of atrial fibrillation in 12 of 31 patients (39%) 
with and in 10 of 31 patients (32%) without residual potentials (p=O.6). Total duration of 
RF energy application was 23.1 f 10.6 and 16.3 + 6.7minutes in patients with and without 
residual potentials (p=O.OB). 
Conciuelons: Low-amplitude and low-frequency residual potentials are occasionally 
observed after PV isolation. These potentials do not predict recurrence of atrial fibriila- 
hon. Attempts to ablate these potentials may result in unnecessary applications of RF 
energy. 
9:30 a.m. 
885-5 Which Is the Optimal Ablation Endpoint for Pulmonary 
Veln Disarticulation? Insight From Circumferential 
Pulmonary Vein Ablation for Atrial Fibrillation 
Carlo, Saivatore Rosanio. Gabrieie Vicedomini. Monica Tocchi. Giuseppe 
Oreto, Cosimo Dicandia. Fiiippo Gugliotta. Adriano Salvati, Vincenzo Santineiii, San 
Raffaele Universify Hospital, Mi/ano, Italy. 
Background: Current approaches to atriai fibrillation (AF) ablation seek to eliminate crit- 
ical connections between left atrlal substrate and arrhythmogenic pulmonary vein (PV) 
triggers. PV potentials can be mapped and eliminated with a limited number of lesions, 
but this approach has limitations due to highly variable PV geometry and muscle fiber 
distributionwe evaluated the relationship of PV potentials to voltage abatment around 
PV ostia obtained by circumferential radiofrequency ablation. Methods: Circumferential 
PV ablation using 3D eiectroanatomicai guidance was performed in 251 patients with 
paroxysmal (n=179) or permanent (n=72) AF. Endpoint for lesion completeness was 
bipolar electrogram amplitude ~0.1 mV inside the circular line. Reeults: Among 960 
lesions surrounding individual PVs (n=956) or 2 ipsilaterai veins with close openings or 
common ostium (n=24). 75% were complete. In preablation maps, PV potentials pre- 
ceded by far-field atrial activity were detected in 401/1146 (35%) near-ostiai points. This 
pattern was mostly observed in superior PVs (superoiateral, n=QQ [BO%]); superoseptai, 
n=62 [67%]) and less frequently in inferior veins (inferolaterai, n=61 [49%]; inferoseptal. 
n=25 [20%]). In postablation maps, PV potentials were not recorded in any of the corn- 
piete lesions, whereas they were found in 106 of 270 incomplete lesions. At 10.4i4.5 
month follow-up, proportion of PVs with complete lesions was similar between patients 
with (n=50) and without (n=201) recurrence. Conclusions: Absence of discrete electrical 
activity within circular lesions correlated with PV potential abolition but not with AF recur- 
rence, suggesting that circumferential PV ablation may alter critical pathways, cardiac 
innervation and other undefined factors to modify AF frequency and physiology beyond 
PV disarticuiation. 
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885-6 Focal Versus Isolation Ablation of Pulmonary Vein 
Trlggers for Atrial Fibrillation: Short-Term Outcome 
mE. David J. Cailans, Erica S. Zado, Andrea J. Russo, Edward P. 
Gerstenfeid. Sanjay Dixit, Robed W. Rho, Vickas Patel, John F. Beshai, Joseph W. Poku, 
David Lin, University of Pennsylvania Healfh System, Philadelphia. Pennsylvania. 
Background: Focal ablation and pulmonary vein(PV) isolation have both been advocated 
as catheter based procedures that can eliminate PV triggers for paroxysmal atral fibriiia- 
tion (PAF). Methods: We compared the outcome following focal (n=42 pts) versus PV iso- 
lation (~41 pts) for frequent drug refractory PAF with triggers isolated to PVs. To provide 
a fair comparison of the two techniques and to decrease the influence of a learning curve 
on outcome: 1) the results represent our single center experience with only the outcome 
of a single operator with z-30 PAF ablation procedures included; 2) the outcome of the 
first 10 pts undergoing focal ablation ware excluded; and 3) only short-term results were 
compared (EP lab negative response to isoproterenol and/or cardioversion and 2 month 
follow up after hospitalization). Only PV with atrial fibrillation triggers documented using 
multipolar catheter recording techniques were targeted during both types of ablation 
strategies. All ablation sites for both techniques were documented and tagged using 
eiectroanatomic mapping. Results: All patients had frequent (mediawdaily with range of 
daily to once/week) symptomatic PAF and had failed a median of 4 drugs. See Table. 
Conclusions: PV isolation appears to facilitate acute elimination of focal triggers originat- 
ing from PVs. This beneficial effect appears more marginal at 2 mos for prevention of AF. 
Both PV isolation and focal trigger ablation can be performed with a low serious compii- 
cation rate. 
Ablation Strategy Focal Trigger Ablation 
n=n3 
PV isolation 
n=d, 
Aw(yr~) 
LA size(cm) 
PAF from PV at end of EP 
PAF at 2 mos 
PV stenosis, Stroke, tamoonade 
50+12 52*12 
4.3 * 0.7 4.3 + 0.6 
5/32 (16%) i/41 (2%) 
1 O/27 (37%) 6/40 (20%) 
0 1 
